Post by A*STAR Infectious Diseases Labs - A*STAR IDL

4,691 followers

๐Ÿงช ๐—•๐—ฟ๐—ถ๐—ฑ๐—ด๐—ถ๐—ป๐—ด ๐—–๐—ต๐—ฒ๐—บ๐—ถ๐˜€๐˜๐—ฟ๐˜† ๐—ฎ๐—ป๐—ฑ ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐˜๐—ผ ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ก๐—ผ๐˜ƒ๐—ฒ๐—น ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ ย  ๐ŸŒ ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น ๐—ฟ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐—ฐ๐—ฒ (๐—”๐— ๐—ฅ) is one of the most pressing global health challenges of our time. As the effectiveness of existing antibiotics continues to decline, there is an urgent need for innovative therapeutic strategies to combat emerging and drug-resistant infections. ย  At A*STAR Infectious Diseases Labs (A*STAR IDL), Dr Ning Li, ๐—ฃ๐—ฟ๐—ถ๐—ป๐—ฐ๐—ถ๐—ฝ๐—ฎ๐—น ๐—œ๐—ป๐˜ƒ๐—ฒ๐˜€๐˜๐—ถ๐—ด๐—ฎ๐˜๐—ผ๐—ฟ and Head of the ๐—”๐—ป๐˜๐—ถ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฏ๐—ถ๐—ฎ๐—น ๐—–๐—ต๐—ฒ๐—บ๐—ถ๐—ฐ๐—ฎ๐—น ๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—Ÿ๐—ฎ๐—ฏ, is leading research at the intersection of ๐—ฐ๐—ต๐—ฒ๐—บ๐—ถ๐˜€๐˜๐—ฟ๐˜† and ๐—ถ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฏ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† to develop ๐—ป๐—ฒ๐˜…๐˜-๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ against fungal, bacterial and viral pathogens. ย  ๐Ÿ”ฌ Taking a highly interdisciplinary approach, Dr Li's team transforms innovative molecular designs into potential therapeutics. Along the way, the team made an unexpected discovery: a compound originally designed as an antibacterial agent failed to inhibit bacterial growth, yet demonstrated highly selective activity against a specific ๐˜Š๐˜ข๐˜ฏ๐˜ฅ๐˜ช๐˜ฅ๐˜ขย fungal species, ๐—ฎ๐—ป ๐—ฒ๐—บ๐—ฒ๐—ฟ๐—ด๐—ถ๐—ป๐—ด ๐—ณ๐˜‚๐—ป๐—ด๐—ฎ๐—น ๐—ฝ๐—ฎ๐˜๐—ต๐—ผ๐—ด๐—ฒ๐—ป ๐—ผ๐—ณ ๐—ด๐—ฟ๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ฐ๐—ผ๐—ป๐—ฐ๐—ฒ๐—ฟ๐—ป ๐—ฑ๐˜‚๐—ฒ ๐˜๐—ผ ๐—ฟ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฟ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—น๐—ถ๐—บ๐—ถ๐˜๐—ฒ๐—ฑ ๐˜๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜ ๐—ผ๐—ฝ๐˜๐—ถ๐—ผ๐—ป๐˜€. ย  โœจ What began as an unforeseen result has since evolved into a promising avenue for ๐—ฝ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐˜๐—ถ๐—ณ๐˜‚๐—ป๐—ด๐—ฎ๐—น ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ถ๐—ฒ๐˜€, highlighting how breakthrough innovations can emerge from unexpected findings. This work recently culminated in a publication in ๐˜ˆ๐˜ฅ๐˜ท๐˜ข๐˜ฏ๐˜ค๐˜ฆ๐˜ฅ ๐˜š๐˜ค๐˜ช๐˜ฆ๐˜ฏ๐˜ค๐˜ฆ. ย  ๐Ÿš€ This research demonstrates how ๐—ฐ๐˜‚๐—ฟ๐—ถ๐—ผ๐˜€๐—ถ๐˜๐˜†-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ, coupled with deep interdisciplinary expertise, can unlock new therapeutic opportunities to combat infectious diseases, strengthen ๐—ฝ๐—ฎ๐—ป๐—ฑ๐—ฒ๐—บ๐—ถ๐—ฐ ๐—ฝ๐—ฟ๐—ฒ๐—ฝ๐—ฎ๐—ฟ๐—ฒ๐—ฑ๐—ป๐—ฒ๐˜€๐˜€, and deliver meaningful impact for ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต. ย  ๐Ÿ‘‡ ๐—Ÿ๐—ฒ๐—ฎ๐—ฟ๐—ป ๐—บ๐—ผ๐—ฟ๐—ฒ ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐——๐—ฟ ๐—Ÿ๐—ถ'๐˜€ ๐˜„๐—ผ๐—ฟ๐—ธ ๐—ต๐—ฒ๐—ฟ๐—ฒ: https://lnkd.in/gjJwY46M ย  Tianjiao Dai | Adrielle Chen | Cynfael Wong | Chloe Esturas Cadag | Zach Yeo Zhong Han | Yenn Chin #ASTARforSG #PandemicPreparedness #InfectiousDiseases #AntimicrobialResistance #AMR #DrugDiscovery #AntifungalResearch #TranslationalResearch #ScientificInnovation

Post contentPost contentPost content